| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.09 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.09 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.3 | 0.09 |